{
    "clinical_study": {
        "@rank": "62223", 
        "arm_group": {
            "arm_group_label": "Vancomycin", 
            "arm_group_type": "Other", 
            "description": "All included patients receive vancomycin for medical reasons. Decision for start of therapy is made by the treating physician."
        }, 
        "brief_summary": {
            "textblock": "Vancomycin is already used for decades in neonates. However, there are remaining questions\n      concerning vancomycin disposition in this population. The purpose of this study is first of\n      all to perform a paired analysis of serum vancomycin concentrations using an immunoassay\n      versus a reference liquid chromatography-tandem mass spectrometry method. Secondly, we aim\n      to determine vancomycin protein binding and its covariates in neonates."
        }, 
        "brief_title": "Exploring Vancomycin Disposition in Neonates", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Neonatal Infection", 
        "detailed_description": {
            "textblock": "Exploration of vancomycin disposition in neonates:\n\n      Objective 1: Paired analysis of (total) serum vancomycin concentrations in neonates using\n      the currently available immunoassay (Cobas c702) versus a reference liquid\n      chromatography-tandem mass spectrometry method (LC-MS/MS).\n\n      Objective 2: The determination of vancomycin protein binding and its covariates in neonates."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Neonates, admitted to the Neonatal Intensive Care Unit to whom vancomycin is\n             administered for medical reasons, can be included in the study after informed consent\n             of the parents.\n\n        Exclusion Criteria:\n\n          -  No vancomycin therapy\n\n          -  No signed informed consent available"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "23 Months", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02096536", 
            "org_study_id": "S56376"
        }, 
        "intervention": {
            "arm_group_label": "Vancomycin", 
            "description": "NA", 
            "intervention_name": "Vancomycin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Vancomycin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Neonate", 
            "Vancomycin", 
            "LC/MS-MS", 
            "protein binding"
        ], 
        "lastchanged_date": "March 21, 2014", 
        "location": {
            "contact": {
                "email": "anne.smits@uzleuven.be", 
                "last_name": "Anne Smits, MD", 
                "phone": "003216341564"
            }, 
            "contact_backup": {
                "email": "karel.allegaert@uzleuven.be", 
                "last_name": "Karel Allegaert, MD,PhD", 
                "phone": "003216343210"
            }, 
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium", 
                    "state": "Vlaams-Brabant", 
                    "zip": "3000"
                }, 
                "name": "UZ Leuven"
            }, 
            "investigator": [
                {
                    "last_name": "Karel Allegaert, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Anne Smits, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "1", 
        "official_title": "Exploring Vancomycin Disposition in Neonates: Paired Analysis of Vancomycin Concentrations Using Immunoassay and Liquid-chromatography-tandem Mass Spectrometry. Determination of Vancomycin Protein Binding and Its Covariates in Neonates", 
        "overall_contact": {
            "email": "anne.smits@uzleuven.be", 
            "last_name": "Anne Smits, MD", 
            "phone": "003216341564"
        }, 
        "overall_contact_backup": {
            "email": "karel.allegaert@uzleuven.be", 
            "last_name": "Karel Allegaert, MD, PhD", 
            "phone": "003216343210"
        }, 
        "overall_official": {
            "affiliation": "UZ Leuven", 
            "last_name": "Anne Smits, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Belgium: Federal Agency for Medicinal Products and Health Products", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Paired vancomycin concentrations in 60 neonates using an immunoassay versus LC/MS-MS method.\nTotal versus unbound vancomycin concentrations in 60 neonates.", 
            "measure": "Differences in vancomycin exposure", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02096536"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Comparisson of the same analytical technique (immunoassay) in fresh (routine clinical care) versus stored samples .", 
            "measure": "Impact of freezing and thawing on vancomycin measurement", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Universitaire Ziekenhuizen Leuven", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universitaire Ziekenhuizen Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}